Prevalence and Associates of Non-fatal Overdose Among People Who Inject Drugs in Saveh, Iran

Overview

Journal Addict Sci Clin Pract

Publisher Biomed Central

Specialty Psychiatry

Date 2022 Aug 4

PMID 35927753

Authors

Bahram Armoon

Mark D Griffiths

Azadeh Bayani

Rasool Mohammadi

Elaheh Ahounbar

Affiliations

Soon will be listed here.

Abstract

Background: As a public health issue, non-fatal overdose (NFOD) is highly prevalent among people who inject drugs (PWID). This can lead to an elevated risk of future overdose, causing various harms including possible death. It is essential to improve knowledge concerning this problem and its associated risk factors to inform overdose prevention and assistance programs. The primary aim of the present study was to determine the prevalence of NFOD and associated risk factors among PWID in Saveh, Iran.

Methods: In the present cross-sectional study, 272 PWID living in Saveh, Iran were interviewed face-to-face using a structured survey. Data concerning socio-demographics, substance use, risky behaviors, and services utilization data were collected. The outcome variable (i.e., NFOD) was assessed by answering "Yes" to the question: "In the past three months, have you ever overdosed (at least once) by accident?"

Results: The prevalence of NFOD among PWID in the past three months was 54%. The characteristics and behaviors that were associated with an increased risk of experiencing NFOD in the past three months were being of older age (AOR = 5.2, p < 0.05), drug use initiation under the age of 22 years (AOR = 7.8, p < 0.05), being an alcohol user (AOR = 3.0, p < 0.05), and being a simultaneous multiple drug user (AOR = 5.8, p < 0.05). Also, more recent initiates to injecting (< 2 years) had an increased risk of experiencing a non-fatal overdose in the past three months. Findings also indicated that those who (i) attended a needle and syringe program (AOR: 0.3, p < 0.05), (ii) were visited by a general practitioner (AOR: 0.03, p < 0.05), and (iii) received a psychosocial intervention (AOR: 0.1, p < 0.05) were 0.3, 0.03 and 0.1 times less likely to report non-fatal overdosing than other participants, respectively.

Conclusions: The results indicate that intervention and prevention initiatives seeking to reduce NFOD among PWID should not only be focused on the primary drug used but also the use of alcohol and polysubstance use. Specific and tailored psychological interventions combined with pharmacotherapy may be highly beneficial for PWID who experience more severe types of substance use, including alcohol use disorders and/or polysubstance abuse.

References

Noroozi M, Marshall B, Noroozi A, Armoon B, Sharifi H, Farhoudian A . Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach. Drug Alcohol Rev. 2017; 37 Suppl 1:S303-S308. DOI: 10.1111/dar.12646. View

Collins L, Pande L, Chung D, Nichols S, McCall K, Piper B . Trends in the medical supply of fentanyl and fentanyl analogues: United States, 2006 to 2017. Prev Med. 2019; 123:95-100. PMC: 8529416. DOI: 10.1016/j.ypmed.2019.02.017. View

Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J . Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2006; 87(1):39-45. DOI: 10.1016/j.drugalcdep.2006.07.009. View

Heinze G, Schemper M . A solution to the problem of separation in logistic regression. Stat Med. 2002; 21(16):2409-19. DOI: 10.1002/sim.1047. View

Bazazi A, Zelenev A, Fu J, Yee I, Kamarulzaman A, Altice F . High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study. Int J Drug Policy. 2014; 26(7):675-81. PMC: 4452449. DOI: 10.1016/j.drugpo.2014.11.010. View

Bird S, Hutchinson S . Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99. Addiction. 2003; 98(2):185-90. DOI: 10.1046/j.1360-0443.2003.00264.x. View

Carroll J, Marshall B, Rich J, Green T . Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. Int J Drug Policy. 2017; 46:136-145. PMC: 5560423. DOI: 10.1016/j.drugpo.2017.05.023. View

Iversen J, Topp L, Wand H, Maher L . Individual-level syringe coverage among Needle and Syringe Program attendees in Australia. Drug Alcohol Depend. 2011; 122(3):195-200. DOI: 10.1016/j.drugalcdep.2011.09.030. View

Green T, Grau L, Blinnikova K, Torban M, Krupitsky E, Ilyuk R . Social and structural aspects of the overdose risk environment in St. Petersburg, Russia. Int J Drug Policy. 2008; 20(3):270-6. PMC: 2696401. DOI: 10.1016/j.drugpo.2008.07.002. View

10.

Zoorob M . Fentanyl shock: The changing geography of overdose in the United States. Int J Drug Policy. 2019; 70:40-46. DOI: 10.1016/j.drugpo.2019.04.010. View

11.

Saini R, Rao R, Parmar A, Mishra A, Ambekar A, Agrawal A . Rates, knowledge and risk factors of non-fatal opioid overdose among people who inject drugs in India: A community-based study. Drug Alcohol Rev. 2019; 39(1):93-97. DOI: 10.1111/dar.13016. View

12.

van de Borne P, Mark A, Montano N, Mion D, Somers V . Effects of alcohol on sympathetic activity, hemodynamics, and chemoreflex sensitivity. Hypertension. 1997; 29(6):1278-83. DOI: 10.1161/01.hyp.29.6.1278. View

13.

Verelst S, Moonen P, Desruelles D, Gillet J . Emergency department visits due to alcohol intoxication: characteristics of patients and impact on the emergency room. Alcohol Alcohol. 2012; 47(4):433-8. DOI: 10.1093/alcalc/ags035. View

14.

Tempalski B, McQuie H . Drugscapes and the role of place and space in injection drug use-related HIV risk environments. Int J Drug Policy. 2008; 20(1):4-13. PMC: 3615636. DOI: 10.1016/j.drugpo.2008.02.002. View

15.

Warner-Smith M, Darke S, Lynskey M, Hall W . Heroin overdose: causes and consequences. Addiction. 2001; 96(8):1113-25. DOI: 10.1046/j.1360-0443.2001.96811135.x. View

16.

Mueller S, Glanz J, Nguyen A, Stowell M, Koester S, Rinehart D . Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose. Int J Drug Policy. 2021; 92:103077. PMC: 9134796. DOI: 10.1016/j.drugpo.2020.103077. View

17.

Schneider K, ORourke A, White R, Park J, Musci R, Kilkenny M . Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone. Int J Drug Policy. 2020; 76:102642. PMC: 7077611. DOI: 10.1016/j.drugpo.2019.102642. View

18.

Des Jarlais D . Harm reduction in the USA: the research perspective and an archive to David Purchase. Harm Reduct J. 2017; 14(1):51. PMC: 5530540. DOI: 10.1186/s12954-017-0178-6. View

19.

Des Jarlais D, McKnight C, Goldblatt C, Purchase D . Doing harm reduction better: syringe exchange in the United States. Addiction. 2009; 104(9):1441-6. DOI: 10.1111/j.1360-0443.2008.02465.x. View

20.

Small W, Rhodes T, Wood E, Kerr T . Public injection settings in Vancouver: physical environment, social context and risk. Int J Drug Policy. 2007; 18(1):27-36. DOI: 10.1016/j.drugpo.2006.11.019. View